戻る Agenda
How the FDA’s MyStudies Platform is Accelerating the Use of Digital Technology in Clinical Research and Clinical Trials
Session Chair(s)
Jameson Rogers, PHD, MS
Product Manager
Google, United States
The FDA MyStudies platform has been used to collect endpoints, PROs, and other real world evidence since its launch in November 2018. Recent open-source enhancements and support by vendors are enabling exciting new studies.
Learning Objective : Describe recent advances in the FDA MyStudies platform; Identify the latest trials and studies leveraging the FDA MyStudies platform; Discuss how the FDA MyStudies platform can be deployed in your own research programs.
Speaker(s)
Panelist
David Martin, MD, MPH
Novartis, United States
Vice President, Head, PCO Center of Excellence
Panelist
Steven Hershman, PHD, MS
Stanford University, United States
Director for Mobile Health
Panelist
Shyam Deval, MBA
Boston Technology Corporation, United States
President